Legal Manufacturer as a Service: Your legal manufacturer for medical devices in over 30 countries

As an experienced legal manufacturer, BAYOOCARE assumes full manufacturer responsibility for your medical device – from classification and CE marking to post-market surveillance. You concentrate on development and marketing, we take overall regulatory responsibility.

BAYOOCARE ist Legal Manufacturer as a Service, Legalhersteller für Medizinprodukte in über 30 Ländern
BAYOOCARE ist Legal Manufacturer as a Service, Legalhersteller für Medizinprodukte in über 30 Ländern

Legal Manufacturer as a Service: Your legal manufacturer for medical devices in over 30 countries

As an experienced legal manufacturer, BAYOOCARE assumes full manufacturer responsibility for your medical device – from classification and CE marking to post-market surveillance. You concentrate on development and marketing, we take overall regulatory responsibility.

What does Legal Manufacturer as a Service mean?

According to MDR and IVDR, a legal manufacturer is the person who places a medical device on the market under their own name, regardless of whether development and production have been outsourced. With our service, you can place medical devices on the market under your brand without having to set up a quality management system in accordance with ISO 13485 yourself. We assume legal responsibility for MDR conformity, manage communication with notified bodies and take care of product liability.

What we do for you

BAYOOCARE has been an expert in placing medical devices and in-vitro diagnostics on the market for over ten years. Our range of services is individually tailored to your needs.

BAYOOCARE - Legal Manufacturer as a Service
  • Launch strategy
  • Distribution

  • Product liability

  • Vigilance, pharmacovigilance and post-market surveillance

  • Technical inspections and testing

  • Hands-on support: practical support in quality management

  • Organization & communication with notified bodies

  • Technical documentation: Complete, audit-proof, MDR-compliant

Still have questions? Please contact uswe know the answer.

Launch strategy:
From the product idea to market approval

We work with you to develop an individual launch strategy and create a concept with trend analyses and correct classification of the product classification. The classification of software medical devices according to Rule 11 of the MDR is particularly critical, as the risk class determines which conformity assessment procedure must be undergone. We analyze your intended purpose, evaluate the risk profile and define the optimal MDR compliance strategy for your target markets.

Distribution:
International market development

As a legal manufacturer in over 30 target countries, we organize the distribution of your medical device in various countries. With our locations in Darmstadt, Berlin, Munich, Basel and London, we act as EU Authorized Representative, CH-Rep (Swiss Authorized Representative) or UK-Rep. These Authorized Representative roles are a prerequisite for manufacturers outside the respective markets to place their products on the market.

Product liability:
Assume legal responsibility

As a legal manufacturer, we assume product liability and legal liability for your medical device. You can market your product under your brand without having to bear the full liability risk. With over ten years of experience – including our EU Regulation 2017/745 certificates for Class IIa (Companion Med App) and Class IIb (NeoDoppler) – we have all the necessary processes and insurance in place.

Hands-on support: practical support in quality management

We support you as a quality management representative (QMA) with internal audits, carry out mock audits in preparation for certification audits and help you set up your QMS.

We are also at your side in the Public Health Action Cycle (PHAC). This practical support is particularly valuable for start-ups launching a medical device on the market for the first time.

Organization & communication with notified bodies

We organize and handle all communication with the notified body – in our case TÜV Süd. Thanks to our many years of cooperation, we know exactly what the expectations, processes and requirements are. For software medical devices, we manage to complete a full conformity assessment procedure within four weeks, without compromising on safety and quality.

Technical inspections
and testing

We coordinate the performance of technical tests by accredited test laboratories, for example electromagnetic compatibility (EMC), electrical safety in accordance with IEC 60601 or biocompatibility tests.

We also carry out the necessary tests, including testing against alarm standards, software validation in accordance with IEC 62304 or usability tests in accordance with IEC 62366.

Contact us

Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device.

Vigilance, pharmacovigilance and post-market surveillance

We systematically monitor and assess risks after the product has been placed on the market. Our vigilance processes include the recording, evaluation and reporting of incidents to the responsible authorities as well as the coordination of Field Safety Corrective Actions (FSCA).

We carry out Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) for you: We continuously collect and analyze post-market data, evaluate trends, identify risks and initiate corrective actions. Our PMS framework includes the collection of customer feedback, complaint analysis, evaluation of scientific literature and systematic evaluation of clinical data.

Technical documentation: Complete, audit-proof, MDR-compliant

We create and maintain your technical documentation in accordance with MDR and IVDR Annex II and III, including the revision of existing documents.

Have you noticed that your Notified Body charges 425 euros per hour for the Tech Doc Review?

We offer a comprehensive preliminary review of your technical documentation before it is submitted to the notified body. This reduces queries, speeds up the review process and saves costs.

Our documentation includes all the necessary elements: device description, design and manufacturing information, full risk assessment, clinical evaluation, benefit-risk analysis and PMS and PMCF plans.

Your advantages: MDSAP, ISO 13485 and
ISO 27001

Our MDSAP and ISO 13485:2016 certification by TÜV Süd offers you strategic advantages for international expansion. The Medical Device Single Audit Program enables simplified market approval in the five MDSAP countries: Australia, Brazil, Canada, Japan and USA. We cover the requirements of these important markets with a single audit – saving time and audit effort.

BAYOOCARE - Wir sind MDSAP und TÜV zertifiziert

MDSAP builds on ISO 13485 and expands it to include authority-specific requirements. The FDA, ANVISA (Brazil) and MHLW (Japan) accept MDSAP audit reports instead of their own audits. The Australian TGA accepts the MDSAP certificate as proof of ISO 13485, and Health Canada uses it to maintain its Canadian license.

Our ISO 27001 certification proves that we systematically manage information security – centrally for digital health applications and software medical devices that process personal health data. We ensure that your technical documentation meets all requirements for GDPR, data security and the basic security and performance requirements.

Medical device compliance:
Individual service for everyone

Our service is as individual as your requirements. Whether you are a MedTech start-up with an initial product idea, a pharmaceutical company adding medical devices to its portfolio or an established medical device manufacturer – we offer the right service. We support you in setting up a quality management system, classification and successful market approval.

Medical technology

As BAYOOCARE, we support you as a MedTech company at every step of your journey – from the development to the successful approval of your medical device.

Pharma

As BAYOOCARE, we accompany you as a pharmaceutical company on your journey – from product development to the successful approval and marketing of your medicinal products.

Start-up

As a young medical technology company, you face many challenges – EU Regulation 2017/745 can quickly become a complex jungle of regulations and requirements.

BAYOOCARE - Internationale Marktzulassung EU, CH, UK, USA

International market authorization:
EU, CH, UK, USA

With our locations in Germany, Switzerland and the UK, we are ideally positioned for your international expansion. Thanks to our local presence, we are familiar with the specific requirements and regulatory peculiarities of the respective markets and can provide you with targeted support for your approval projects.

BAYOOCARE - Unsere Standorte in Europa ermöglichen uns Representative für die EU, Schweiz und UK zu sein

Contact us

Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device.

Frequently asked questions

International market approval raises many questions. We have answered the most common ones for you – from the role of the legal manufacturer to MDSAP certification and country-specific requirements. Your question is not listed? Please feel free to contact us.

Basics of market authorization

A legal manufacturer bears full responsibility for the design, manufacture, packaging and labeling of medical devices, places products on the market under its own name and is responsible for CE marking, technical documentation, ISO 13485 quality management system and post-market surveillance. This role can also be outsourced to specialized service providers.

The duration depends on the risk class and complexity. Software medical devices with a complete conformity assessment procedure can be approved within four weeks if all documents have been prepared. For more complex products in higher risk classes or products with necessary clinical studies, the process can take several months to years.

According to the MDR, classification is based on the intended purpose and the risk. Rule 11 of the MDR regulates software classification from Class I to III. The decisive factors are therapeutic or diagnostic function, severity of the disease and whether the software makes treatment decisions. The classification determines the required conformity assessment procedure.

ISO 13485:2016 is the international standard for quality management systems in the medical device industry. Certification is a prerequisite for market approval in many countries. In the EU, a certified QM system in accordance with ISO 13485 is required for medical devices from class IIa. MDSAP is based on ISO 13485.

PMS is the systematic collection, analysis and evaluation of data after market launch. It includes monitoring product safety and performance, recording incidents, trend analyses and corrective measures. Clinical follow-up (PMCF) is part of this. According to the MDR, manufacturers must draw up PMS plans, submit regular PMS reports and update the clinical evaluation.

International markets & services

Outsourcing enables rapid market access, as the legal manufacturer already has ISO 13485 certification. You save costs for your own QM system and regulatory personnel, avoid time-consuming certification and can concentrate on development and marketing. In addition, the liability risk is transferred and regulatory expertise is immediately available.

These Authorized Representatives represent manufacturers in various markets. An EU Authorized Representative (EU Rep) represents manufacturers from non-EU countries in accordance with Art. 11 MDR. A CH Rep is the interface to Swissmedic in Switzerland. A UK Rep is required for the UK after Brexit. They all perform similar tasks: Registration, communication with authorities, provision of technical documentation.

MDSAP (Medical Device Single Audit Program) enables manufacturers to meet the regulatory requirements of five countries with a single audit: Australia, Brazil, Canada, Japan and the USA. The program is based on ISO 13485:2016 and integrates country-specific requirements. In Canada, MDSAP has been mandatory for medical device manufacturers since 2019.

BAYOOCARE - Alfred Koch - CEO & PRRC

Alfred Koch

CEO | PRRC

How to contact us

Are you planning a project or do you have very specific regulatory questions about placing your medical device on the market? No matter what phase of your project you are in, we will be happy to support you. The quickest way to contact us – feel free to write to us.

Contact form

Preferred contact method
Data protection notice *